BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2786689)

  • 41. Heparin, its fractions, fragments and derivatives. Some newer perspectives.
    Fareed J
    Semin Thromb Hemost; 1985 Jan; 11(1):1-9. PubMed ID: 3919446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional requirements for inhibition of thrombin by antithrombin III in the presence and absence of heparin.
    Tsiang M; Jain AK; Gibbs CS
    J Biol Chem; 1997 May; 272(18):12024-9. PubMed ID: 9115268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and characterisation of the pathological antithrombin III "Aalborg".
    Sørensen PJ; Ezban M; Jessen TE; Sas G; Blasko G; Jørgensen M
    Thromb Res; 1990 Mar; 57(5):807-12. PubMed ID: 2339371
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibitory activities for thrombin and factor Xa of whale heparin: comparative studies on two preparations from different species.
    Ototani N; Yosizawa Z
    Tohoku J Exp Med; 1986 Sep; 150(1):77-82. PubMed ID: 3775773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
    Scully MF; Ellis V; Shah N; Kakkar V
    Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The characteristics of anticoagulation by covalently immobilized heparin.
    Miura Y; Aoyagi S; Kusada Y; Miyamoto K
    J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of polycations on the inhibitory action of antithrombin III on thrombin in the absence and presence of polyanions.
    Schiele U; Heuck CC
    Thromb Res; 1986 Jul; 43(2):187-93. PubMed ID: 3738858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inactivation of alpha- and beta- thrombin by antithrombin-III and heparin.
    Machovich R; Blaskó G; Borsodi A
    Thromb Haemost; 1976 Dec; 36(3):503-8. PubMed ID: 65798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of heparin on the extent of inhibition of thrombin by heparin cofactor.
    Owen WG
    Biochim Biophys Acta; 1977 Sep; 494(1):182-90. PubMed ID: 71165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conformational changes accompanying the binding of antithrombin III to thrombin.
    Villanueva G; Danishefsky I
    Biochemistry; 1979 Mar; 18(5):810-7. PubMed ID: 420817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding.
    Huntington JA; Olson ST; Fan B; Gettins PG
    Biochemistry; 1996 Jul; 35(26):8495-503. PubMed ID: 8679610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of surface charge on the accelerating action of heparin on the antithrombin III-inhibited activity of alpha-thrombin.
    Heuck CC; Schiele U; Horn D; Fronda D; Ritz E
    J Biol Chem; 1985 Apr; 260(8):4598-603. PubMed ID: 3988727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preliminary biochemical and pharmacologic studies on a chemically synthesized pentasaccharide.
    Walenga JM; Fareed J
    Semin Thromb Hemost; 1985 Apr; 11(2):89-99. PubMed ID: 4035370
    [No Abstract]   [Full Text] [Related]  

  • 57. The relative molecular mass dependence of the anti-factor Xa properties of heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Sep; 238(2):329-33. PubMed ID: 3800942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Demonstration of a two-step reaction mechanism for inhibition of alpha-thrombin by antithrombin III and identification of the step affected by heparin.
    Olson ST; Shore JD
    J Biol Chem; 1982 Dec; 257(24):14891-5. PubMed ID: 7174671
    [No Abstract]   [Full Text] [Related]  

  • 59. Reaction of antithrombin with proteases. Evidence for a specific reaction with papain.
    Valeri AM; Wilson SM; Feinman RD
    Biochim Biophys Acta; 1980 Aug; 614(2):526-33. PubMed ID: 7407200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M; Holmer E; de Mol M; Collen D
    Thromb Haemost; 1983 Apr; 49(2):109-15. PubMed ID: 6868006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.